IL33 and Hepatic fibrosis: Although earlier we introduced the idea that IL-33 could alleviate HFD-induced hepatic steatosis and insulin resistance, it has been verified that in diet-induced NASH, IL-33-mediated aggravation of hepatic fibrosis was dependent on the ST2 signalling pathway [39].